Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

3.65
Delayed Data
As of Sep 23
 -0.04 / -1.08%
Today’s Change
2.38
Today|||52-Week Range
5.57
-13.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-61.9M-85.3M9.4M-92.8M
 
 
 
 
 
Depreciation4.4M4.5M3.7M1.5M
 
 
 
 
 
Total Other Cash Flow22.0M5.1M-25.9M13.7M
 
 
 
 
 
Funds From Operations-35.6M-75.7M-12.8M-77.7M
 
 
 
 
 
Funds From/For Other Operating Expenses51.5M-4.0M-7.0M-7.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-87.1M-71.7M-5.8M-70.1M
 
 
 
 
 
 
InvestingIncrease In Investments-110.7M-95.6M-202.9M-139.2M
 
 
 
 
 
Decrease In Investments96.7M100.7M143.6M208.3M
 
 
 
 
 
Capital Expenditures-2.3M-2.6M-2.5M-3.2M
 
 
 
 
 
Fixed Asset Disposal----3.8M0.00
 
 
Net Cash Flow Investing-16.4M2.5M-58.0M66.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings128.1M-86.0K0.000.00
 
 
 
Long Term Debt Reduction-92.7M0.000.000.00
 
 
Net Proceeds Stock Sale73.0M77.1M50.9M4.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.0046.0K
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing108.4M77.1M50.9M5.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash4.9M7.9M-12.9M907.0K